|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 300 for Map3k7

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.058s

Categories

Category: Publication
« show all
Type Details Score
Publication
29281682 | J:255565
First Author: Brown K
Year: 2017
Journal: PLoS One
Title: Overexpression of Map3k7 activates sinoatrial node-like differentiation in mouse ES-derived cardiomyocytes.
Volume: 12
Issue: 12
Pages: e0189818
•
•
•
•
•
Publication
29667914 | J:264364
First Author: Karolak MJ
Year: 2018
Journal: Am J Physiol Renal Physiol
Title: Inactivation of MAP3K7 in FOXD1-expressing cells results in loss of mesangial PDGFRΒ and juvenile kidney scarring.
Volume: 315
Issue: 2
Pages: F336-F344
•
•
•
•
•
Publication
17085580 | J:117108
First Author: Xie M
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway.
Volume: 103
Issue: 46
Pages: 17378-83
•
•
•
•
•
Publication
16186825 | J:112597
First Author: Sato S
Year: 2005
Journal: Nat Immunol
Title: Essential function for the kinase TAK1 in innate and adaptive immune responses.
Volume: 6
Issue: 11
Pages: 1087-95
•
•
•
•
•
Publication
36062803 | J:332172
First Author: Rodrigues M
Year: 2022
Journal: Biochem J
Title: TAK1 protein kinase activity is required for TLR signalling and cytokine production in myeloid cells.
Volume: 479
Issue: 17
Pages: 1891-1907
•
•
•
•
•
Publication
32513687 | J:294169
First Author: Tan S
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.
Volume: 117
Issue: 25
Pages: 14231-14242
•
•
•
•
•
Publication
25278099 | J:234149
First Author: Li L
Year: 2014
Journal: Circulation
Title: Transforming growth factor β-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling.
Volume: 130
Issue: 24
Pages: 2162-72
•
•
•
•
•
Publication
16799562 | J:112646
First Author: Wan YY
Year: 2006
Journal: Nat Immunol
Title: The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function.
Volume: 7
Issue: 8
Pages: 851-8
•
•
•
•
•
Publication
29415881 | J:283261
 
First Author: Hindi SM
Year: 2018
Journal: JCI Insight
Title: TAK1 regulates skeletal muscle mass and mitochondrial function.
Volume: 3
Issue: 3
•
•
•
•
•
Publication
22143887 | J:179050
First Author: Ridder DA
Year: 2011
Journal: J Exp Med
Title: TAK1 in brain endothelial cells mediates fever and lethargy.
Volume: 208
Issue: 13
Pages: 2615-23
•
•
•
•
•
Publication
16857737 | J:111794
First Author: Liu HH
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: Essential role of TAK1 in thymocyte development and activation.
Volume: 103
Issue: 31
Pages: 11677-82
•
•
•
•
•
Publication
29196442 | J:258269
 
First Author: Muthukrishnan SD
Year: 2018
Journal: Dis Model Mech
Title: Nephron progenitor cell death elicits a limited compensatory response associated with interstitial expansion in the neonatal kidney.
Volume: 11
Issue: 1
•
•
•
•
•
Publication
20080763 | J:156517
First Author: Inokuchi S
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis.
Volume: 107
Issue: 2
Pages: 844-9
•
•
•
•
•
Publication
20959492 | J:166056
First Author: Omori E
Year: 2010
Journal: Cancer Res
Title: Ablation of TAK1 upregulates reactive oxygen species and selectively kills tumor cells.
Volume: 70
Issue: 21
Pages: 8417-25
•
•
•
•
•
Publication
16940043 | J:112837
First Author: Sato S
Year: 2006
Journal: Int Immunol
Title: TAK1 is indispensable for development of T cells and prevention of colitis by the generation of regulatory T cells.
Volume: 18
Issue: 10
Pages: 1405-11
•
•
•
•
•
Publication
24983318 | J:213859
First Author: Inokuchi-Shimizu S
Year: 2014
Journal: J Clin Invest
Title: TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis.
Volume: 124
Issue: 8
Pages: 3566-78
•
•
•
•
•
Publication
16754690 | J:116458
First Author: Sayama K
Year: 2006
Journal: J Biol Chem
Title: Transforming growth factor-beta-activated kinase 1 is essential for differentiation and the prevention of apoptosis in epidermis.
Volume: 281
Issue: 31
Pages: 22013-20
•
•
•
•
•
Publication
26132627 | J:238318
First Author: Sanjo H
Year: 2015
Journal: PLoS One
Title: Conditional Deletion of TAK1 in T Cells Reveals a Pivotal Role of TCRαβ+ Intraepithelial Lymphocytes in Preventing Lymphopenia-Associated Colitis.
Volume: 10
Issue: 7
Pages: e0128761
•
•
•
•
•
Publication
20585657 | J:222365
First Author: Sayama K
Year: 2010
Journal: PLoS One
Title: Inflammatory mediator TAK1 regulates hair follicle morphogenesis and anagen induction shown by using keratinocyte-specific TAK1-deficient mice.
Volume: 5
Issue: 6
Pages: e11275
•
•
•
•
•
Publication
27473013 | J:236007
 
First Author: Yao P
Year: 2016
Journal: Toxicol Appl Pharmacol
Title: Lack of TAK1 in dendritic cells inhibits the contact hypersensitivity response induced by trichloroethylene in local lymph node assay.
Volume: 307
Pages: 72-80
•
•
•
•
•
Publication
32622875 | J:303338
 
First Author: Strong AL
Year: 2020
Journal: Bone
Title: Small molecule inhibition of non-canonical (TAK1-mediated) BMP signaling results in reduced chondrogenic ossification and heterotopic ossification in a rat model of blast-associated combat-related lower limb trauma.
Volume: 139
Pages: 115517
•
•
•
•
•
Publication
32979244 | J:303689
First Author: Zhao F
Year: 2021
Journal: Glia
Title: Tak1 in the astrocytes of mediobasal hypothalamus regulates anxiety-like behavior in mice.
Volume: 69
Issue: 3
Pages: 609-618
•
•
•
•
•
Publication
23340735 | J:197953
First Author: Guo F
Year: 2013
Journal: J Invest Dermatol
Title: TAK1 is required for dermal wound healing and homeostasis.
Volume: 133
Issue: 6
Pages: 1646-54
•
•
•
•
•
Publication
21367917 | J:210583
First Author: Ma FY
Year: 2011
Journal: Am J Physiol Renal Physiol
Title: TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney.
Volume: 300
Issue: 6
Pages: F1410-21
•
•
•
•
•
Publication
19675569 | J:245318
First Author: Xia ZP
Year: 2009
Journal: Nature
Title: Direct activation of protein kinases by unanchored polyubiquitin chains.
Volume: 461
Issue: 7260
Pages: 114-9
•
•
•
•
•
Publication
10757786 | J:61571
First Author: Takatsu Y
Year: 2000
Journal: Mol Cell Biol
Title: TAK1 participates in c-Jun N-terminal kinase signaling during Drosophila development.
Volume: 20
Issue: 9
Pages: 3015-26
•
•
•
•
•
Publication
15647289 | J:98019
First Author: Kobayashi Y
Year: 2005
Journal: J Biol Chem
Title: Prostaglandin E2 enhances osteoclastic differentiation of precursor cells through protein kinase A-dependent phosphorylation of TAK1.
Volume: 280
Issue: 12
Pages: 11395-403
•
•
•
•
•
Publication
15911626 | J:100815
First Author: Hoffmann A
Year: 2005
Journal: J Biol Chem
Title: Transforming growth factor-beta-activated kinase-1 (TAK1), a MAP3K, interacts with Smad proteins and interferes with osteogenesis in murine mesenchymal progenitors.
Volume: 280
Issue: 29
Pages: 27271-83
•
•
•
•
•
Publication
19201899 | J:144781
First Author: Kumar M
Year: 2009
Journal: J Immunol
Title: TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-beta-activated kinase 1.
Volume: 182
Issue: 4
Pages: 2439-48
•
•
•
•
•
Publication
19197243 | J:146482
First Author: Herrero-Martín G
Year: 2009
Journal: EMBO J
Title: TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells.
Volume: 28
Issue: 6
Pages: 677-85
•
•
•
•
•
Publication
22683931 | J:192411
First Author: White BJ
Year: 2012
Journal: Exp Neurol
Title: Protection from cerebral ischemia by inhibition of TGFβ-activated kinase.
Volume: 237
Issue: 1
Pages: 238-45
•
•
•
•
•
Publication
23505428 | J:200194
First Author: Vink PM
Year: 2013
Journal: PLoS One
Title: In vivo knockdown of TAK1 accelerates bone marrow proliferation/differentiation and induces systemic inflammation.
Volume: 8
Issue: 3
Pages: e57348
•
•
•
•
•
Publication
21475303 | J:203101
First Author: Neubert M
Year: 2011
Journal: Cell Death Differ
Title: Acute inhibition of TAK1 protects against neuronal death in cerebral ischemia.
Volume: 18
Issue: 9
Pages: 1521-30
•
•
•
•
•
Publication
25146924 | J:230218
First Author: Mihaly SR
Year: 2014
Journal: Cell Death Differ
Title: TAK1 control of cell death.
Volume: 21
Issue: 11
Pages: 1667-76
•
•
•
•
•
Publication
31461199 | J:294104
First Author: Onodera Y
Year: 2019
Journal: Stem Cells
Title: Transforming Growth Factor β-Activated Kinase 1 Regulates Mesenchymal Stem Cell Proliferation Through Stabilization of Yap1/Taz Proteins.
Volume: 37
Issue: 12
Pages: 1595-1605
•
•
•
•
•
Publication
27246297 | J:303016
First Author: Suddason T
Year: 2016
Journal: Cell Cycle
Title: Genetic insights into Map3k-dependent proliferative expansion of T cells.
Volume: 15
Issue: 15
Pages: 1956-60
•
•
•
•
•
Publication
32382778 | J:319329
First Author: Zeyen T
Year: 2020
Journal: J Mol Med (Berl)
Title: Microglial-specific depletion of TAK1 is neuroprotective in the acute phase after ischemic stroke.
Volume: 98
Issue: 6
Pages: 833-847
•
•
•
•
•
Publication
8533096 | J:47270
First Author: Yamaguchi K
Year: 1995
Journal: Science
Title: Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction.
Volume: 270
Issue: 5244
Pages: 2008-11
•
•
•
•
•
Publication
15894542 | J:188905
First Author: Hocevar BA
Year: 2005
Journal: J Biol Chem
Title: Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway.
Volume: 280
Issue: 27
Pages: 25920-7
•
•
•
•
•
Publication
26102028 | J:228674
First Author: Sumiya E
Year: 2015
Journal: Biochem Biophys Res Commun
Title: Phosphoproteomic analysis of kinase-deficient mice reveals multiple TAK1 targets in osteoclast differentiation.
Volume: 463
Issue: 4
Pages: 1284-90
•
•
•
•
•
Publication
22348103 | J:211916
First Author: Eftychi C
Year: 2012
Journal: PLoS One
Title: Myeloid TAKI [corrected] acts as a negative regulator of the LPS response and mediates resistance to endotoxemia.
Volume: 7
Issue: 2
Pages: e31550
•
•
•
•
•
Publication
25418008 | J:233358
 
First Author: Qi B
Year: 2014
Journal: Sci Rep
Title: Ablation of Tak1 in osteoclast progenitor leads to defects in skeletal growth and bone remodeling in mice.
Volume: 4
Pages: 7158
•
•
•
•
•
Publication
30582764 | J:279111
First Author: Ye P
Year: 2019
Journal: Hepatology
Title: Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression.
Volume: 69
Issue: 5
Pages: 1946-1964
•
•
•
•
•
Publication
27230958 | J:236046
First Author: Mia S
Year: 2016
Journal: Biochem Biophys Res Commun
Title: Role of AMP-activated protein kinase α1 in angiotensin-II-induced renal Tgfß-activated kinase 1 activation.
Volume: 476
Issue: 4
Pages: 267-272
•
•
•
•
•
Publication
37071470 | J:337956
 
First Author: Roy A
Year: 2023
Journal: JCI Insight
Title: Targeted regulation of TAK1 counteracts dystrophinopathy in a DMD mouse model.
Volume: 8
Issue: 10
•
•
•
•
•
Publication
24144697 | J:211846
First Author: Gao L
Year: 2013
Journal: J Cell Sci
Title: TAK1 regulates SOX9 expression in chondrocytes and is essential for postnatal development of the growth plate and articular cartilages.
Volume: 126
Issue: Pt 24
Pages: 5704-13
•
•
•
•
•
Publication
26648529 | J:228303
 
First Author: Ogura Y
Year: 2015
Journal: Nat Commun
Title: TAK1 modulates satellite stem cell homeostasis and skeletal muscle repair.
Volume: 6
Pages: 10123
•
•
•
•
•
Publication
29796309 | J:280219
 
First Author: Soni D
Year: 2018
Journal: Cell Death Discov
Title: Deubiquitinase function of A20 maintains and repairs endothelial barrier after lung vascular injury.
Volume: 4
Pages: 60
•
•
•
•
•
Publication
18829460 | J:143466
First Author: Inagaki M
Year: 2008
Journal: J Biol Chem
Title: TAK1-binding protein 1, TAB1, mediates osmotic stress-induced TAK1 activation but is dispensable for TAK1-mediated cytokine signaling.
Volume: 283
Issue: 48
Pages: 33080-6
•
•
•
•
•
Publication
29855498 | J:262742
First Author: Biswas S
Year: 2018
Journal: Sci Rep
Title: BMPRIA is required for osteogenic differentiation and RANKL expression in adult bone marrow mesenchymal stromal cells.
Volume: 8
Issue: 1
Pages: 8475
•
•
•
•
•
Publication
24077561 | J:207425
First Author: Goldmann T
Year: 2013
Journal: Nat Neurosci
Title: A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation.
Volume: 16
Issue: 11
Pages: 1618-26
•
•
•
•
•
Publication
20037161 | J:161669
First Author: Bhatnagar S
Year: 2010
Journal: J Biol Chem
Title: Transforming growth factor-beta-activated kinase 1 is an essential regulator of myogenic differentiation.
Volume: 285
Issue: 9
Pages: 6401-11
•
•
•
•
•
Publication
31393024 | J:302419
First Author: Guo WZ
Year: 2020
Journal: Hepatology
Title: Six-Transmembrane Epithelial Antigen of the Prostate 3 Deficiency in Hepatocytes Protects the Liver Against Ischemia-Reperfusion Injury by Suppressing Transforming Growth Factor-β-Activated Kinase 1.
Volume: 71
Issue: 3
Pages: 1037-1054
•
•
•
•
•
Publication
32349637 | J:304190
First Author: Wu X
Year: 2020
Journal: J Am Heart Assoc
Title: CARD3 Promotes Cerebral Ischemia-Reperfusion Injury Via Activation of TAK1.
Volume: 9
Issue: 9
Pages: e014920
•
•
•
•
•
Publication
21771792 | J:176611
First Author: Rajasekaran K
Year: 2011
Journal: J Biol Chem
Title: Transforming growth factor-beta-activated kinase 1 regulates natural killer cell-mediated cytotoxicity and cytokine production.
Volume: 286
Issue: 36
Pages: 31213-24
•
•
•
•
•
Publication
18606807 | J:142025
First Author: Omori E
Year: 2008
Journal: J Biol Chem
Title: TAK1 regulates reactive oxygen species and cell death in keratinocytes, which is essential for skin integrity.
Volume: 283
Issue: 38
Pages: 26161-8
•
•
•
•
•
Publication
24833394 | J:211255
First Author: Shinohara H
Year: 2014
Journal: Science
Title: Positive feedback within a kinase signaling complex functions as a switch mechanism for NF-κB activation.
Volume: 344
Issue: 6185
Pages: 760-4
•
•
•
•
•
Publication
31813254 | J:290480
First Author: Zhou J
Year: 2020
Journal: Am J Physiol Renal Physiol
Title: TAK1 deficiency attenuates cisplatin-induced acute kidney injury.
Volume: 318
Issue: 1
Pages: F209-F215
•
•
•
•
•
Publication
19196865 | J:148728
First Author: Schuman J
Year: 2009
Journal: Blood
Title: A critical role of TAK1 in B-cell receptor-mediated nuclear factor kappaB activation.
Volume: 113
Issue: 19
Pages: 4566-74
•
•
•
•
•
Publication
25452303 | J:224303
First Author: Ivshina M
Year: 2015
Journal: Mol Cell Biol
Title: CPEB regulation of TAK1 synthesis mediates cytokine production and the inflammatory immune response.
Volume: 35
Issue: 3
Pages: 610-8
•
•
•
•
•
Publication
36974751 | J:335520
First Author: Qian Q
Year: 2023
Journal: J Am Heart Assoc
Title: SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1-Dependent Manner.
Volume: 12
Issue: 7
Pages: e028628
•
•
•
•
•
Publication
12711537 | J:83326
First Author: Jadrich JL
Year: 2003
Journal: Gene Expr Patterns
Title: Expression of TAK1, a mediator of TGF-beta and BMP signaling, during mouse embryonic development.
Volume: 3
Issue: 2
Pages: 131-4
•
•
•
•
•
Publication
20062539 | J:157244
First Author: Lluis JM
Year: 2010
Journal: PLoS One
Title: TAK1 is required for survival of mouse fibroblasts treated with TRAIL, and does so by NF-kappaB dependent induction of cFLIPL.
Volume: 5
Issue: 1
Pages: e8620
•
•
•
•
•
Publication
24534530 | J:209902
First Author: Gu M
Year: 2014
Journal: J Immunol
Title: Phosphatase holoenzyme PP1/GADD34 negatively regulates TLR response by inhibiting TAK1 serine 412 phosphorylation.
Volume: 192
Issue: 6
Pages: 2846-56
•
•
•
•
•
Publication
25521315 | J:246417
First Author: Kong F
Year: 2015
Journal: Immunology
Title: Transforming growth factor-β-activated kinase 1 resistance limits glucocorticoid responsiveness to Toll-like receptor 4-mediated inflammation.
Volume: 145
Issue: 1
Pages: 136-49
•
•
•
•
•
Publication
30765691 | J:276457
First Author: Wang L
Year: 2019
Journal: Nat Commun
Title: PLCβ2 negatively regulates the inflammatory response to virus infection by inhibiting phosphoinositide-mediated activation of TAK1.
Volume: 10
Issue: 1
Pages: 746
•
•
•
•
•
Publication
31301769 | J:291391
First Author: Wang L
Year: 2019
Journal: Biochem Biophys Res Commun
Title: USP10 protects against cerebral ischemia injury by suppressing inflammation and apoptosis through the inhibition of TAK1 signaling.
Volume: 516
Issue: 4
Pages: 1272-1278
•
•
•
•
•
Publication
33133065 | J:305849
 
First Author: Jiangqiao Z
Year: 2020
Journal: Front Immunol
Title: Ubiquitin-Specific Peptidase 10 Protects Against Hepatic Ischaemic/Reperfusion Injury via TAK1 Signalling.
Volume: 11
Pages: 506275
•
•
•
•
•
Publication
35842423 | J:342240
First Author: Zou Y
Year: 2022
Journal: Cell Death Dis
Title: Deficiency of PPP6C protects TNF-induced necroptosis through activation of TAK1.
Volume: 13
Issue: 7
Pages: 618
•
•
•
•
•
Publication
19927120 | J:155547
First Author: Sato Y
Year: 2009
Journal: EMBO J
Title: Structural basis for specific recognition of Lys 63-linked polyubiquitin chains by NZF domains of TAB2 and TAB3.
Volume: 28
Issue: 24
Pages: 3903-9
•
•
•
•
•
Publication
30975711 | J:276680
First Author: Sai K
Year: 2019
Journal: J Cell Biol
Title: Necroptosis mediators RIPK3 and MLKL suppress intracellular Listeria replication independently of host cell killing.
Volume: 218
Issue: 6
Pages: 1994-2005
•
•
•
•
•
Publication
30683914 | J:296194
First Author: Yang L
Year: 2019
Journal: Cell Death Differ
Title: TAK1 regulates endothelial cell necroptosis and tumor metastasis.
Volume: 26
Issue: 10
Pages: 1987-1997
•
•
•
•
•
Publication
23166301 | J:194222
First Author: Lamothe B
Year: 2013
Journal: Mol Cell Biol
Title: TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis.
Volume: 33
Issue: 3
Pages: 582-95
•
•
•
•
•
Publication
23251462 | J:195668
First Author: Lamothe B
Year: 2012
Journal: PLoS One
Title: Deletion of TAK1 in the myeloid lineage results in the spontaneous development of myelomonocytic leukemia in mice.
Volume: 7
Issue: 12
Pages: e51228
•
•
•
•
•
Publication
22226633 | J:180736
First Author: Ajibade AA
Year: 2012
Journal: Immunity
Title: TAK1 negatively regulates NF-κB and p38 MAP kinase activation in Gr-1+CD11b+ neutrophils.
Volume: 36
Issue: 1
Pages: 43-54
•
•
•
•
•
Publication
24980047 | J:214726
First Author: Xiao Y
Year: 2014
Journal: J Exp Med
Title: TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling.
Volume: 211
Issue: 8
Pages: 1689-702
•
•
•
•
•
Publication
28013046 | J:251597
First Author: Wu L
Year: 2017
Journal: Biochem Biophys Res Commun
Title: Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice.
Volume: 483
Issue: 2
Pages: 810-815
•
•
•
•
•
Publication
22331902 | J:182165
First Author: Omori E
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: Epithelial transforming growth factor β-activated kinase 1 (TAK1) is activated through two independent mechanisms and regulates reactive oxygen species.
Volume: 109
Issue: 9
Pages: 3365-70
•
•
•
•
•
Publication
24498425 | J:212972
First Author: Ikeda Y
Year: 2014
Journal: PLoS One
Title: TAK1 binding protein 2 is essential for liver protection from stressors.
Volume: 9
Issue: 2
Pages: e88037
•
•
•
•
•
Publication
21383695 | J:174637
First Author: Omori E
Year: 2011
Journal: Oncogene
Title: Non-canonical β-catenin degradation mediates reactive oxygen species-induced epidermal cell death.
Volume: 30
Issue: 30
Pages: 3336-44
•
•
•
•
•
Publication
18573910 | J:137388
First Author: Tang M
Year: 2008
Journal: J Exp Med
Title: TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice.
Volume: 205
Issue: 7
Pages: 1611-9
•
•
•
•
•
Publication
19234607 | J:146227
First Author: Kim JY
Year: 2009
Journal: PLoS One
Title: Intestinal epithelial-derived TAK1 signaling is essential for cytoprotection against chemical-induced colitis.
Volume: 4
Issue: 2
Pages: e4561
•
•
•
•
•
Publication
24120137 | J:211910
First Author: He G
Year: 2013
Journal: Cell
Title: Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling.
Volume: 155
Issue: 2
Pages: 384-96
•
•
•
•
•
Publication
20064449 | J:156178
First Author: Long M
Year: 2009
Journal: Immunity
Title: Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor.
Volume: 31
Issue: 6
Pages: 921-31
•
•
•
•
•
Publication
22307082 | J:181911
First Author: Pathak S
Year: 2012
Journal: EMBO J
Title: O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release.
Volume: 31
Issue: 6
Pages: 1394-404
•
•
•
•
•
Publication
31982140 | J:292200
First Author: Wu YK
Year: 2020
Journal: Biochem Biophys Res Commun
Title: Targeting DUSP16/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK.
Volume: 524
Issue: 1
Pages: 142-149
•
•
•
•
•
Publication
18762249 | J:259108
First Author: Winkel A
Year: 2008
Journal: Cell Signal
Title: Wnt-ligand-dependent interaction of TAK1 (TGF-beta-activated kinase-1) with the receptor tyrosine kinase Ror2 modulates canonical Wnt-signalling.
Volume: 20
Issue: 11
Pages: 2134-44
•
•
•
•
•
Publication
19026643 | J:201312
First Author: Liu XY
Year: 2008
Journal: FEBS Lett
Title: HSP90 is required for TAK1 stability but not for its activation in the pro-inflammatory signaling pathway.
Volume: 582
Issue: 29
Pages: 4023-31
•
•
•
•
•
Publication
16360132 | J:105724
First Author: Watkins SJ
Year: 2006
Journal: Cardiovasc Res
Title: A direct interaction between TGFbeta activated kinase 1 and the TGFbeta type II receptor: implications for TGFbeta signalling and cardiac hypertrophy.
Volume: 69
Issue: 2
Pages: 432-9
•
•
•
•
•
Publication
19419968 | J:151178
First Author: Tan SH
Year: 2009
Journal: J Biol Chem
Title: Regulation of cell proliferation and migration by TAK1 via transcriptional control of von Hippel-Lindau tumor suppressor.
Volume: 284
Issue: 27
Pages: 18047-58
•
•
•
•
•
Publication
27601471 | J:237278
First Author: Oho M
Year: 2016
Journal: J Biol Chem
Title: TIPE2 (Tumor Necrosis Factor α-induced Protein 8-like 2) Is a Novel Negative Regulator of TAK1 Signal.
Volume: 291
Issue: 43
Pages: 22650-22660
•
•
•
•
•
Publication
23391818 | J:310605
First Author: Yang L
Year: 2013
Journal: Gastroenterology
Title: Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
Volume: 144
Issue: 5
Pages: 1042-1054.e4
•
•
•
•
•
Publication
12556533 | J:84524
First Author: Li MG
Year: 2003
Journal: J Biol Chem
Title: Regulation of the interleukin-1-induced signaling pathways by a novel member of the protein phosphatase 2C family (PP2Cepsilon).
Volume: 278
Issue: 14
Pages: 12013-21
•
•
•
•
•
Publication
17709393 | J:148055
First Author: Blanco S
Year: 2007
Journal: Mol Cell Biol
Title: Vaccinia-related kinase 2 modulates the stress response to hypoxia mediated by TAK1.
Volume: 27
Issue: 20
Pages: 7273-83
•
•
•
•
•
Publication
29291351 | J:262344
First Author: Ji YX
Year: 2018
Journal: Nat Med
Title: The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis.
Volume: 24
Issue: 2
Pages: 213-223
•
•
•
•
•
Publication
20813258 | J:166091
First Author: Oh DY
Year: 2010
Journal: Cell
Title: GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects.
Volume: 142
Issue: 5
Pages: 687-98
•
•
•
•
•
Publication
20194509 | J:163054
First Author: Li M
Year: 2010
Journal: J Biol Chem
Title: TAB2 scaffolds TAK1 and NLK in repressing canonical Wnt signaling.
Volume: 285
Issue: 18
Pages: 13397-404
•
•
•
•
•
Publication
23972991 | J:202855
First Author: Vucur M
Year: 2013
Journal: Cell Rep
Title: RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation.
Volume: 4
Issue: 4
Pages: 776-90
•
•
•
•
•
Publication
28182011 | J:317359
First Author: Sakamachi Y
Year: 2017
Journal: Cell Death Dis
Title: TAK1 regulates resident macrophages by protecting lysosomal integrity.
Volume: 8
Issue: 2
Pages: e2598
•
•
•
•
•
Publication
32071228 | J:285746
First Author: Naito MG
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke.
Volume: 117
Issue: 9
Pages: 4959-4970
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom